FDA Clearance Tracker · P990004-S028
SURGIFOAM ABSORBABLE GELATIN SPONGE, USP
Last checked: Nov 20, 2026Latest source record: Feb 5, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Feb 5, 2016
Approved
Time to decision
336 days
Received Mar 6, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P990004-S028
- Device name
- SURGIFOAM ABSORBABLE GELATIN SPONGE, USP
- Applicant
- Ferrosan Meidcal Devices A/S
- Applicant location
- Soeborg
- Received
- Mar 6, 2015
- Decided
- Feb 5, 2016
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P990004
Device type
- Device class
- Class III
- Regulation
- 21 CFR 878.4490
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
approval for a manufacturing site located at SteriPack Medical Poland SP.ZO.O., Poland, for the contract packaging of the SURGIFLO Hemostatic Matrix Device and thesterilizing site located at Synergy Health Ede BV, Netherlands, for the sterilization of theSURGIFLO Hemostatic
Source documents
Other decisions for Ferrosan Meidcal Devices A/S
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.